GGrantIndex
Sort

85,873 grants matching alzheimers

Modulation of the Innate Immune Response by Fisetin Derivatives for the Treatment of AD

$967,956
William C Raschke · Virogenics, Inc. · R44 · FY2019 · AI

Online Training & Certification for Competency in Dementia Friendly Hospital Care

$967,947
John V Hobday · Healthcare Interactive, Inc. · R44 · FY2015 · AG

The delivery of essential fatty acids to the Brain in Alzheimer's disease

$967,845
Hussein N Yassine · University Of Southern California · R01 · FY2019 · AG

EPIDEMIOLOGY OF DEMENTIA IN CACHE COUNTY, UTAH

$967,753
Johns Hopkins University · R01 · FY2000 · AG

Video Rate Photothermal Infrared Spectroscopy (VR-PTIR)

$967,628
Craig Prater · Photothermal Spectroscopy Corp. · R44 · FY2024 · GM

Recruitment and Retention Core

$967,539
David K Johnson · University Of California At Davis · U19 · FY2025 · NS

Recruitment and Retention Core

$967,534
David K Johnson · University Of California At Davis · U19 · FY2024 · NS

Recruitment and Retention Core

$967,528
David K Johnson · University Of California At Davis · U19 · FY2023 · NS

Mechanisms of neurotransmitter release and its regulation

$967,526
Jose Rizo-Rey · Ut Southwestern Medical Center · R35 · FY2023 · NS

Impact of ovarian hormone suppression on regional and global brain architecture and cognition

$967,229
Matthew S Panizzon · University Of California, San Diego · R01 · FY2020 · AG

Clinical Core

$967,128
Arjun Vijay Masurkar · New York University School Of Medicine · P30 · FY2021 · AG

DATA MANAGEMENT & STATISTICS

$966,266
J. Philip Miller · Washington University · P50 · FY2008 · AG

Safety and Tolerability Studies for an Anti-Fibrin P2 Monoclonal Antibody for the Treatment of Alzheimer's Disease

$966,254
Aaron B Kantor · Therini Bio, Inc. · U01 · FY2023 · AG

Alzheimers Disease Mechanism & Experimental Therapeutic

$966,142
Philip C Wong · Johns Hopkins University · P01 · FY2008 · NS

2/2 Brain, Behavior and Genetic Studies of the 22q11 Deletion Studies

$966,115
Beverly S Emanuel · Children'S Hosp Of Philadelphia · U01 · FY2010 · MH

Development of recombinant Lecithin Cholesterol Acyltransferase as a therapeutic

$965,897
Alan Remaley · National Heart, Lung, And Blood Institute · ZIA · FY2015 · HL

Project 4: Cross-species Dissection of Cellular Response to APOE Genotype and AD Pathology Using Single-cell Multi-omics

$965,724
Michael Ryan Corces · J. David Gladstone Institutes · P01 · FY2021 · AG

Modulation of the Innate Immune Response by Fisetin Derivatives for the Treatment of AD

$965,711
William C Raschke · Virogenics, Inc. · R44 · FY2020 · AI

Alzheimers Disease Mechanism & Experimental Therapeutic

$965,650
Philip C Wong · Johns Hopkins University · P01 · FY2007 · NS

Single Cell Characterization of FTLD-GRN

$965,344
Eric J Huang · University Of California, San Francisco · R01 · FY2025 · NS

Core F: Biomarker Core

$965,132
Arnold Bakker · Johns Hopkins University · P30 · FY2022 · AG

Biosynthesis, Processing And Secretion Of Neuropeptides And Pituitary Hormones

$965,080
Yoke P Loh · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2012 · HD

Tracking autobiographical thoughts: a smartphone-based approach to identifying cognitive correlates of Alzheimer's disease biomarkers and risk factors in clinically normal older adults

$965,074
Matthew D Grilli · University Of Arizona · R01 · FY2025 · AG

ACETYLCHOLINE MODULATION OF NEURONAL EXCITABILITY

$965,064
Harvard University (Medical School) · P01 · FY2001 · NS

Core B: Clinical Core

$965,032
Douglas R Galasko · University Of California, San Diego · P30 · FY2024 · AG